PeopleBio, Inc. (KOSDAQ:304840)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,694.00
-116.00 (-6.41%)
At close: Nov 19, 2025
-6.41%
Market Cap35.86B
Revenue (ttm)3.13B
Net Income (ttm)-9.10B
Shares Out21.17M
EPS (ttm)-418.99
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume351,769
Average Volume927,549
Open1,810.00
Previous Close1,810.00
Day's Range1,682.00 - 1,812.00
52-Week Range1,320.00 - 4,600.00
Beta0.30
RSI58.44
Earnings DateNov 14, 2025

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2002
Employees 47
Stock Exchange KOSDAQ
Ticker Symbol 304840
Full Company Profile

Financial Performance

In 2024, PeopleBio's revenue was 3.73 billion, a decrease of -16.20% compared to the previous year's 4.45 billion. Losses were -10.91 billion, -31.94% less than in 2023.

Financial Statements

News

There is no news available yet.